side effects glp 1 agonist Adverse of GLP-1 Receptor Agonists Long-Term Effects Of GLP-1 Medications:
Description
The MHRA opened a formal investigation in 2025 (O'Dowd, 2025)
PMCID: PMC7919569
Sattar, D
Primary Data Analysis To address potential confounding, we extracted adjusted risk estimates when available and noted the covariates included in each study's analysis model(s)
Additionally, the loss of fatty acids compromises the skin barrier, resulting in dryness
A multicenter phase IIb RCT in NASH with fibrosis stages 1-3 demonstrated the efficacy of resmetirom in reducing hepatic steatosis at 12 and 36 weeks compared with placebo
